Axon Enterprise, Inc.

(NASDAQ Global Select)
Back to all articles
Slightly Bullish +25

Why Is Axon (AXON) Down 11.5% Since Last Earnings Report?

AI-generated analysis

πŸ“‰ Shares of Axon Enterprise (AXON) have declined approximately 11.5% over the last month, significantly underperforming the S&P 500.

πŸ’° The company reported Q4 2025 adjusted earnings of $2.15 per share, exceeding the consensus estimate of $1.67 and rising 3.4% year-over-year.

πŸ“¦ Total revenues reached $797 million in Q4 2025, surpassing estimates by beating expectations with a 39% year-over-year increase.

πŸ’³ Full-year 2025 net revenue totaled $2.78 billion, marking a 33.5% increase, while adjusted earnings per share reached $6.85 (up 15.3%).

πŸ”§ Revenue growth was driven by strong demand for key products including the TASER 10, Axon Body 4, and counter-drone equipment.

πŸ“Š Analysts are now split between two business segments: Connected Devices ($454.2M revenue) and Software & Services ($342.5M revenue).

⚠️ Adjusted gross margins declined in both segments for Q4 2025 due to tariff impacts, a higher mix of lower-margin products, and increased operating expenses.

πŸ’Έ Operating cash flow generated in 2025 was $211.3 million, down from $408.3 million the prior year, with adjusted free cash flow dropping to $85.6 million.

πŸš€ Management forecasts Q1-Q4 2026 revenue growth of 27-30% and anticipates achieving annual revenues of $6 billion by 2028.

βš™οΈ Planned capital expenditures for 2026 range between $185 million and $215 million to fund R&D, capacity expansion, and new product development.

πŸ“‰ Recent investor sentiment has led analysts to revise downward on fresh estimates, shifting the consensus estimate by -76.6%.

πŸ” Axon currently holds an average Growth Score of C, a Momentum Score of A, but a Value grade of F (bottom 20% quintile).

πŸ›‘ Based on these metrics, Axon has been assigned a Zacks Rank #3 (Hold) with expectations for in-line returns in the coming months.

Bullish Signals
  • Axon reported fourth-quarter 2025 adjusted earnings of $2.15 per share, significantly beating the Zacks Consensus Estimate of $1.67.
  • Total revenues reached $797 million, surpassing the consensus estimate of $753.6 million and growing 39% year over year driven by strong demand for TASER 10, Axon Body 4, and counter-drone equipment.
  • In 2025, the company reported net revenues of $2.78 billion, an increase of 33.5% year over year.
  • For the Software & Services segment, revenues rose 39.8% year over year to $342.5 million due to growing adoption of premium software offerings and an increase in the aggregate number of users.
  • Axon expects revenues to grow between 27-30% year over year in 2026 with an adjusted EBITDA margin projected at 25.5%.
  • The company anticipates achieving annual revenues of $6 billion by 2028, with an adjusted EBITDA margin expected to be about 28%.
  • Management plans to limit annual dilution from stock-based compensation to less than 2.5%, ensuring a controlled capital structure for future growth.
Risk Factors
  • Shares have dropped 11.5% since the last earnings report, underperforming the S&P 500.
  • Adjusted free cash flow significantly decreased to $85.6 million in 2025 from $344.3 million in the prior-year period.
  • Operating expenses climbed 41.1% year over year, while net operating cash flow declined 48.2% to $211.3 million.
  • The stock received a grade of F on the value side and sits in the bottom 20% quintile for the investment strategy.
  • Analyst consensus estimates have shifted down by -76.6%, with investors witnessing a downward trend in fresh estimates.
  • The Zacks Rank is #3 (Hold), which typically indicates an expectation of only in-line returns rather than significant outperformance.
  • Despite strong revenue growth, the adjusted gross margin decreased to 61.1% from 63.2%, attributed to global tariff impacts and higher product mix.
Full Analysis
Axon Enterprise, Inc. (AXON) shares have declined approximately 11.5% since its fourth-quarter 2025 earnings report released over a month ago, underperforming the broader S&P 500 despite reporting strong financial results that beat consensus estimates. In Q4 2025, the company delivered adjusted earnings of $2.15 per share versus an expectation of $1.67, and revenues reached $797 million compared to a forecast of $753.6 million. These top-line results were driven by robust demand for its TASER 10 devices, Axon Body 4 body-worn cameras, counter-drone equipment, and increasing adoption of premium software solutions across both its newly aligned business segments: Connected Devices and Software & Services. The broader fiscal year 2025 saw net revenues increase by 33.5% to $2.78 billion, with adjusted earnings rising 15.3% to $6.85 per share. However, the company faced margin pressure as its adjusted gross margin decreased to 61.1% from the prior year, primarily due to global tariff-related impacts and a shift toward higher-margin Platform Solutions products within the Connected Devices segment. Cash flow metrics showed a significant reduction in operating cash generation for 2025 at $211.3 million compared to $408.3 million in the previous year, while adjusted free cash flow dropped to $85.6 million from $344.3 million, though the company holds substantial cash reserves of $1.2 billion as of the end of Q4 2025. Looking ahead, management expects revenues for fiscal 2026 to grow between 27% and 30% year over year with an adjusted EBITDA margin target of 25.5%. The company plans to reinvest between $185 million and $215 million in capital expenditures for capacity expansion, facility build-outs, and research and development, anticipating stock-based compensation expenses of roughly $230 million. Long-term guidance includes a projection to reach $6 billion in annual revenues by 2028 with an adjusted EBITDA margin of approximately 28%, alongside a goal to limit dilution from equity compensation to less than 2.5% annually. Following the earnings release, analyst sentiment has shifted negatively, leading to downward revisions in consensus estimates that have contributed to the stock's current Zacks Rank #3 (Hold) rating and an aggregate VGM Score of D. While the stock holds an A-grade Momentum Score based on recent technical performance, it carries a C-grade Growth Score and an F-grade Value Score, placing it in the bottom 20% for value-based investment strategies. The article concludes with an expectation of in-line returns over the coming months and notes that the stock operates within the Zacks Aerospace - Defense Equipment industry.